
BridgeBio Pharma launches CoA Therapeutics to Target Coenzyme-A for Rare Genetic Disorders
06.13.2018
page
of 8
news
Catch up on news from BridgeBio and its companies and follow developments about the promising treatments in our pipeline. Follow us on LinkedIn to keep up with all the latest news.
Links to an external site